Sign In
Buy LLY
$1,131.42
+6.04 (+0.537%)
At Close: Jun 05, 2026
Why Eli Lilly (LLY) is a Top Momentum Stock for the Long-Term
11:18am, Thursday, 13'th Jun 2024
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
3 Stocks to Buy as Ozempic Surges in Popularity
06:15am, Thursday, 13'th Jun 2024
Ozempic and Wegovy (semaglutide for diabetes and weight loss, respectively) are popular weight-loss drugs that have taken the world by storm. Indeed, the craze is showing no signs of slowing down as m
Want to Get Richer? 2 Top Stocks to Buy Now and Hold Forever.
05:55am, Thursday, 13'th Jun 2024
You won't want to miss out on the stock Warren Buffett has been scooping up. A healthcare leader is poised to capture the lion's share of a potential $130 billion weight loss market.
4 Best Stocks to Buy and 3 Best Stocks to Sell: June 2024
02:24pm, Wednesday, 12'th Jun 2024
It remains a tale of two markets. Some stocks have wind in their sails and are soaring to all-time highs.
Alzheimer's in Focus as FDA Panel Endorses Lilly's Donanemab
11:26am, Wednesday, 12'th Jun 2024
If Eli Lilly's (LLY) donanemab is approved by the FDA, it will become the second drug approved by the FDA to reduce the clinical decline associated with Alzheimer's disease.
A Life Expansion Revolution Is Coming: 3 Stocks That Could Lead the Charge
07:30am, Wednesday, 12'th Jun 2024
Artificial intelligence is forecast to drive an innovation bonanza in healthcare. This innovation boom is expected to increase the human lifespan dramatically.
Is Eli Lilly the Best Pharmaceutical Stock for You?
05:25am, Wednesday, 12'th Jun 2024
Eli Lilly's revenue has taken off thanks to two of its drugs that doctors prescribe for weight loss. The company also has a full portfolio of other products, and some increased revenue in the double d
Jim Cramer looks at Eli Lilly's outlook as the company's Alzheimer drug goes through FDA
08:14pm, Tuesday, 11'th Jun 2024
'Mad Money' host Jim Cramer breaks down Eli Lilly's success in pharmaceutical drugs and where the stock can go from here.
Eli Lilly may have developed the greatest drug of all time, says Jim Cramer
08:12pm, Tuesday, 11'th Jun 2024
'Mad Money' host Jim Cramer breaks down Eli Lilly's success in pharmaceutical drugs and where the stock can go from here.
Eli Lilly closer to securing FDA approval for Alzheimer's drug
05:09pm, Tuesday, 11'th Jun 2024
Eli Lilly (LLY) is one step closer to getting its new Alzheimer's treatment approved by the Food and Drug Administration (FDA) after a panel voted to recommend its use. BMO Capital Markets Managing Di
Eli Lilly Continues To Climb As Alzheimer's Drug Gains FDA Approval
02:24pm, Tuesday, 11'th Jun 2024
Eli Lilly and Company has gained approval on yet another prospective blockbuster drug, Donanemab, the second FDA-approved Alzheimer's treatment on the market. It is too soon to know what kind of impac
Eli Lilly's Donanemab Gains Favorable FDA Advisory Verdict, Boosting Stock Potential, Says BofA Analyst
02:19pm, Tuesday, 11'th Jun 2024
BofA Securities analyst Geoff Meacham reiterated the Buy rating on Eli Lilly And Company LLY, with a price forecast of $1,000.
Eli Lilly: The Road To Approval Of Donanemab Is Open
02:00pm, Tuesday, 11'th Jun 2024
Eli Lilly's stock has seen significant gains due to the success of its GLP-1 franchise and the potential of donanemab for Alzheimer's disease. The FDA's Advisory Committee endorsed donanemab for Alzhe
Here's Why Eli Lilly Will Likely Announce a Stock Split
01:35pm, Tuesday, 11'th Jun 2024
24/7 Wall Street Insights Unlike the declining stocks of some of its pharmaceutical rivals, Eli Lilly has continually beat analysts' forecasts and prospered accordingly.
Eli Lilly Drags Alzheimer's Stocks Prothena, Eisai Lower Despite FDA Win
12:20pm, Tuesday, 11'th Jun 2024
Eli Lilly stock reversed premarket gains at the open Tuesday after an FDA panel endorsed its Alzheimer's treatment, donanemab.
